Name: GSK Bepirovirsen Catalyst
Start: 2026-04-29

GSK plc

Catalyst AI-extracted

Bepirovirsen

chronic hepatitis B

Resolved

69days ago

Catalyst readout · Apr 29, 2026

What's at stake A key catalyst for Bepirovirsen (chronic hepatitis B) is expected Apr 29, 2026.

Primary source · SEC 6-K verified 12h ago

“regulatory filings accepted in US, EU, China and Japan.”

1 source on file.

Link copied ✓